[Lung cancer and COPD: a common combination]. / Cáncer de pulmón y EPOC: una asociación frecuente.
Arch Bronconeumol
; 45(10): 502-7, 2009 Oct.
Article
em Es
| MEDLINE
| ID: mdl-19748721
BACKGROUND AND OBJECTIVE: To analyse frequency, characteristics and patient survival with lung cancer (LC) and COPD, comparing them with patients without COPD. MATERIAL AND METHODS: A retrospective study, of patients diagnosed by means of cytohistology. Survival was estimated by the Kaplan-Meier method. The statistical analysis was carried out using SPSS 15.0. RESULTS: A total of 996 patients were diagnosed, 39.8% COPD. Mean age 70+/-9.19 years. GOLD stages: I 18.2%, II 53.6%, III 24%, IV 4.2%. The histological types: squamous cell carcinoma 48.2%, adenocarcinoma 22%, small cell carcinoma 22.5%. Survival was longer in the COPD group. CONCLUSIONS: LC and COPD are combined in 39.8%. Squamous cell type is more frequent and survival was longer in the COPD group.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carcinoma de Células Escamosas
/
Adenocarcinoma
/
Doença Pulmonar Obstrutiva Crônica
/
Carcinoma de Pequenas Células do Pulmão
/
Neoplasias Pulmonares
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Es
Revista:
Arch Bronconeumol
Ano de publicação:
2009
Tipo de documento:
Article